Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Classical hematology 2Other hematologic neoplasm 1Myeloid 1Gastrointestinal 1

Conditions

Thrombocytopenia 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia 1Colorectal Neoplasms 1

Interventions

eltrombopag 6romiplostim 4avatrombopag 4Cytarabine 4Daunorubicin 3Cyclophosphamide 3oprelvekin 2hetrombopag 2Tretinoin 2Tranexamic Acid 2Radiotherapy 2Platelet Transfusion 2Filgrastim 2Etoposide 2Carboplatin 2sodium thiosulfate 1raltitrexed 1pegfilgrastim 1ofatumumab 1niraparib 1leridistim 1fludarabine 1etoposide phosphate 1angiotensin I (1-7) 1Vorinostat 1Vincristine 1Thioguanine 1Stem Cell Transplantation 1Sirolimus 1Rituximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Thrombocytopenia × oprelvekin × Clear all
NCT03823079 2019-01-30

Comparison of Interleukin-11 and rhTPO for Recurrent Colorectal Cancer Patients With Thrombocytopenia

Fudan University

Phase 2 Unknown
50 enrolled
Classical hematologyGastrointestinal

Thrombocytopenia, Colorectal Neoplasms

NCT00493181 2012-02-20

Interleukin 11, Thrombocytopenia, Imatinib in Chronic Myelogenous Leukemia (CML) Patients

M.D. Anderson Cancer Center

Phase 2 Completed
8 enrolled 3 charts
Classical hematologyMyeloidOther hematologic neoplasm

Leukemia, Thrombocytopenia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡